Patents by Inventor Daniel Freeman

Daniel Freeman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11396512
    Abstract: This invention relates to compounds of general Formula (I) and pharmaceutically acceptable salts thereof, in which R1, R2, R2A, R2B, R3, R4, R5A, R5B, R6, R7, R8, R9, p, q and r are as defined herein, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: July 26, 2022
    Assignee: Pfizer Inc.
    Inventors: Douglas Carl Behenna, Ping Chen, Kevin Daniel Freeman-Cook, Robert Louis Hoffman, Mehran Jalaie, Asako Nagata, Sajiv Krishnan Nair, Sacha Ninkovic, Martha Alicia Ornelas, Cynthia Louise Palmer, Eugene Yuanjin Rui
  • Publication number: 20220095695
    Abstract: An inhalation device for e.g., nicotine products which receives a user input regulating the amount of nicotine the user wants to receive. Once the selected amount has been delivered to the user, the device shuts off its atomizer to conclude operation.
    Type: Application
    Filed: December 8, 2021
    Publication date: March 31, 2022
    Applicant: INDOSE INC
    Inventors: Ari FREEMAN, Daniel FREEMAN, Jacqueline FREEMAN, Benzi RONEN, John DALE, George BERNOTA, Mike DAUGHTERY, Kelly MCQUINN
  • Publication number: 20220092429
    Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media, for training a neural network. One of the methods includes performing, using a plurality of training examples, a training step to obtain respective gradients of a loss function with respect to each of the parameters in the parameter tensors; obtaining a validation loss for a plurality of validation examples that are different from the plurality of training examples generating an optimizer input from at least the respective gradients and the validation loss; processing the optimizer input using an optimizer neural network to generate an output defining a respective update for each of the parameters in the parameter tensors of the neural network; and for each of the parameters in the parameter tensors, applying the respective update to a current value of the parameter to generate an updated value for the parameter.
    Type: Application
    Filed: September 21, 2021
    Publication date: March 24, 2022
    Inventors: Luke Shekerjian Metz, Niruban Maheswaranathan, Christian Daniel Freeman, Benjamin Poole, Jascha Narain Sohl-Dickstein
  • Publication number: 20220068623
    Abstract: Electrospray devices and methods of fabricating electrospray devices are described
    Type: Application
    Filed: August 31, 2020
    Publication date: March 3, 2022
    Applicant: Massachusetts Institute of Technology
    Inventors: Melissa Alyson Smith, Donna-Ruth Yost, Daniel Freeman, Noah Siegel, Paulo C. Lozano
  • Publication number: 20220005008
    Abstract: A key-duplicating system comprises a network that includes a multiplicity of kiosks at a multiplicity of different locations, each of the kiosks having a customer interface and a processor coupled to the customer interface. A remote central server coupled to the kiosks is adapted to receive, from the kiosks, information identifying master keys to be duplicated.
    Type: Application
    Filed: September 17, 2021
    Publication date: January 6, 2022
    Applicant: THE HILLMAN GROUP, INC.
    Inventor: Daniel FREEMAN
  • Patent number: 11213687
    Abstract: This disclosure provides systems and methods for delivering a neural stimulation pulse. A neural implant device can include an energy harvesting circuit configured to receive an input signal and generate an electrical signal based on the received input signal. A diode rectifier in series with the energy harvesting circuit can rectify the electrical signal. The energy harvesting circuit and the diode rectifier can be encapsulated within a biocompatible electrically insulating material. A neural electrode can be exposed through the biocompatible electrically insulating material. The neural electrode can be configured to deliver a neural stimulation pulse. The neural implant device can have a volume that is less than about 1.0 cubic millimeter.
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: January 4, 2022
    Assignee: THE CHARLES STARK DRAPER LABORATORY, INC.
    Inventors: Jonathan Bernstein, Daniel Freeman, Reed Irion, Brett Ingersoll, Amy Duwel, Andrew Czarnecki, Brian Daniels, Anilkumar Harapanahalli Achyuta, Bryan McLaughlin
  • Patent number: 11203594
    Abstract: This invention relates to compounds of general Formula I in which A, R1, R2, R3 and R4 are as defined herein, and the pharmaceutically acceptable salts thereof; to pharmaceutical compositions comprising such compounds and salts; to methods of using such compounds, salts and compositions for treating pulmonary hypertension and related diseases, like pulmonary arterial hypertension; to methods of using such compounds, salts and compositions for treating abnormal cell growth, such as cancer; and to processes to make such compounds, salts and compositions.
    Type: Grant
    Filed: April 15, 2020
    Date of Patent: December 21, 2021
    Assignee: Pfizer Inc.
    Inventors: Samit Kumar Bhattacharya, Douglas Carl Behenna, Kimberly O. Cameron, Ping Chen, John M. Curto, Kevin Daniel Freeman-Cook, Mehran Jalaie, Robert Steven Kania, Yajing Lian, Sajiv Krishnan Nair, Cynthia Louise Palmer, Martin Youngjin Pettersson, Eugene Yuanjin Rui, Matthew Sammons, Qingyi Yang, Liying Zhang
  • Patent number: 11170356
    Abstract: A key-duplicating system comprises a network that includes a multiplicity of kiosks at a multiplicity of different locations, each of the kiosks having a customer interface and a processor coupled to the customer interface. A remote central server coupled to the kiosks is adapted to receive, from the kiosks, information identifying master keys to be duplicated. A key analysis module uses the information identifying master keys to be duplicated to derive information required to produce duplicates of the identified master keys, and a key duplicating module uses that information to produce duplicates of said identified master keys.
    Type: Grant
    Filed: February 19, 2020
    Date of Patent: November 9, 2021
    Assignee: The Hillman Group, Inc.
    Inventor: Daniel Freeman
  • Publication number: 20210269425
    Abstract: This invention relates to compounds of Formula (I) and enantiomers thereof, and to pharmaceutically acceptable salts of Formula (I) and said enantiomers, wherein R1, R2 and R3 are as defined herein. The invention further relates to pharmaceutical compositions comprising such compounds and salts, and to methods and uses of such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer, in a subject in need thereof.
    Type: Application
    Filed: April 20, 2021
    Publication date: September 2, 2021
    Applicant: Pfizer Inc.
    Inventors: Douglas Carl Behenna, Kevin Daniel Freeman-Cook, Robert Louis Hoffman, Asako Nagata, Sacha Ninkovic, Scott Channing Sutton
  • Publication number: 20210261530
    Abstract: This invention relates to compounds of Formula (I) and enantiomers thereof, and to pharmaceutically acceptable salts of Formula (I) and said enantiomers, wherein R1, R2 and R3 are as defined herein. The invention further relates to pharmaceutical compositions comprising such compounds and salts, and to methods and uses of such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer, in a subject in need thereof.
    Type: Application
    Filed: April 20, 2021
    Publication date: August 26, 2021
    Applicant: Pfizer Inc.
    Inventors: Douglas Carl Behenna, Kevin Daniel Freeman-Cook, Robert Louis Hoffman, Asako Nagata, Sacha Ninkovic, Scott Channing Sutton
  • Publication number: 20210258881
    Abstract: Methods and systems in which a portable electronic device can be voice activated are disclosed. The portable electronic device can be a multi-function electronic device. The voice activation can be robust and context sensitive. The voice activation can also be utilized without any preparatory user action with respect to the portable electronic device. The portable electronic device can also interact with a media system.
    Type: Application
    Filed: April 19, 2021
    Publication date: August 19, 2021
    Inventors: Daniel FREEMAN, Derek B. BARRENTINE
  • Patent number: 11076634
    Abstract: A metered smoking apparatus includes a burnable media including indicia that visually represent a plurality of smokable units of a smokable substance or an active ingredient thereof, each of the smokable units corresponding to a same predetermined quantity of the smokable substance or the active ingredient thereof, and when the smokable substance is rolled within the burnable media, the burnable media is configured such that the indicia are sequentially burned in a burn line direction that is a direction in which a burn line burns when the metered smoking apparatus is smoked, to thereby indicate consumption of the predetermined quantity on a unit-by-unit basis.
    Type: Grant
    Filed: September 11, 2018
    Date of Patent: August 3, 2021
    Assignee: ELEMENT EXTREME LLC
    Inventor: Daniel Freeman
  • Patent number: 11014911
    Abstract: This invention relates to compounds of Formula (I) and enantiomers thereof, and to pharmaceutically acceptable salts of Formula (I) and said enantiomers, wherein R1, R2 and R3 are as defined herein. The invention further relates to pharmaceutical compositions comprising such compounds and salts, and to methods and uses of such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer, in a subject in need thereof.
    Type: Grant
    Filed: January 28, 2020
    Date of Patent: May 25, 2021
    Assignee: Pfizer Inc.
    Inventors: Douglas Carl Behenna, Kevin Daniel Freeman-Cook, Robert Louis Hoffman, Asako Nagata, Sacha Ninkovic, Scott Channing Sutton
  • Patent number: 11012942
    Abstract: Methods and systems in which a portable electronic device can be voice to activated are disclosed. The portable electronic device can be a multi-function electronic device. The voice activation can be robust and context sensitive. The voice activation can also be utilized without any preparatory user action with respect to the portable electronic device. The portable electronic device can also interact with a media system.
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: May 18, 2021
    Assignee: Apple Inc.
    Inventors: Daniel Freeman, Derek B. Barrentine
  • Publication number: 20200392142
    Abstract: This invention relates to compounds of general Formula (1) and pharmaceutically acceptable salts thereof, in which R1, R2, R2A, R2B, R3, R4, R5A, R5B, R6, R7, R8, R9, p, q and r are as defined herein, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer.
    Type: Application
    Filed: August 27, 2020
    Publication date: December 17, 2020
    Applicant: Pfizer Inc.
    Inventors: Douglas Carl Behenna, Ping Chen, Kevin Daniel Freeman-Cook, Robert Louis Hoffman, Mehran Jalaie, Asako Nagata, Sajiv Krishnan Nair, Sacha Ninkovic, Martha Alicia Ornelas, Cynthia Louise Palmer, Eugene Yuanjin Rui
  • Patent number: 10859620
    Abstract: Aspects are generally directed to a compact and low-noise electric field detector, methods of operation, and methods of production thereof. In one example, an electric field detector includes a proof mass, a source of concentrated charge coupled to the proof mass, and a substrate having a substrate offset space defined therein, the proof mass being suspended above the substrate offset space. The electric field detector further includes a sense electrode disposed on the substrate within the substrate offset space and proximate the proof mass, the sense electrode being configured to measure a change in capacitance relative to the proof mass from movement of the proof mass in response to a received electric field at the source of concentrated charge. The electric field detector includes a control circuit coupled to the sense electrode and configured to determine a characteristic of the electric field based on the measured change in capacitance.
    Type: Grant
    Filed: April 3, 2018
    Date of Patent: December 8, 2020
    Assignee: THE CHARLES STARK DRAPER LABORATORY, INC.
    Inventors: James A. Bickford, Stephanie Lynne Golmon, Paul A. Ward, William D. Sawyer, Marc S. Weinberg, John J. LeBlanc, Louis Kratchman, James S. Pringle, Jr., Daniel Freeman, Amy Duwel, Max Lindsay Turnquist, Ronald Steven McNabb, Jr., William A. Lenk
  • Publication number: 20200331075
    Abstract: An automatic key duplicating machine is disclosed. A master key identification module includes at least one key blade cross-section detector with a plurality of sliding elements, the master key identification module being configured to determine a key type for a master key based at least in part on engagement of the plurality of sliding elements with a blade profile of the master key. A key extraction module is configured to retrieve a key blank of an identified key type. A key cutting module is configured to cut the key blank in accordance with a tooth pattern of the master key.
    Type: Application
    Filed: July 1, 2020
    Publication date: October 22, 2020
    Inventors: Daniel FREEMAN, Ari FREEMAN
  • Publication number: 20200331909
    Abstract: This invention relates to compounds of general Formula I in which A, R1, R2, R3 and R4 are as defined herein, and the pharmaceutically acceptable salts thereof; to pharmaceutical compositions comprising such compounds and salts; to methods of using such compounds, salts and compositions for treating pulmonary hypertension and related diseases, like pulmonary arterial hypertension; to methods of using such compounds, salts and compositions for treating abnormal cell growth, such as cancer; and to processes to make such compounds, salts and compositions.
    Type: Application
    Filed: April 15, 2020
    Publication date: October 22, 2020
    Applicant: Pfizer Inc.
    Inventors: Samit Kumar Bhattacharya, Douglas Carl Behenna, Kimberly O. Cameron, Ping Chen, John M. Curto, Kevin Daniel Freeman-Cook, Mehran Jalaie, Robert Steven Kania, Yajing Lian, Sajiv Krishnan Nair, Cynthia Louise Palmer, Martin Youngjin Pettersson, Eugene Yuanjin Rui, Matthew Sammons, Qingyi Yang, Liying Zhang
  • Patent number: 10800783
    Abstract: This invention relates to compounds of general Formula (I) and pharmaceutically acceptable salts thereof, in which R1, R2, R2A, R2B, R3, R4, R5A, R5B, R6, R7, R8, R9, p, q and r are as defined herein, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer.
    Type: Grant
    Filed: January 17, 2019
    Date of Patent: October 13, 2020
    Assignee: Pfizer Inc.
    Inventors: Douglas Carl Behenna, Ping Chen, Kevin Daniel Freeman-Cook, Robert Louis Hoffman, Mehran Jalaie, Asako Nagata, Sajiv Krishnan Nair, Sacha Ninkovic, Martha Alicia Ornelas, Cynthia Louise Palmer, Eugene Yuanjin Rui
  • Publication number: 20200305084
    Abstract: Methods and systems in which a portable electronic device can be voice to activated are disclosed. The portable electronic device can be a multi-function electronic device. The voice activation can be robust and context sensitive. The voice activation can also be utilized without any preparatory user action with respect to the portable electronic device. The portable electronic device can also interact with a media system.
    Type: Application
    Filed: January 31, 2020
    Publication date: September 24, 2020
    Inventors: Daniel FREEMAN, Derek B. BARRENTINE